CVS Health swings to Q3 net income of $2.17 billion
CVS•CVS Health reported third-quarter GAAP diluted earnings of $1.68 per share and revenue of $108.4 billion, up 5% year over year, and raised its 2026 guidance to at least $6.98 in GAAP diluted EPS and $15.5 billion in operating cash flow.
1. Quarterly results and outlook
CVS Health swung to third-quarter GAAP diluted earnings of $1.68 per share, reflecting the absence of a prior-year goodwill impairment charge. Revenue rose 5% year over year to $108.4 billion, primarily driven by growth in Health Services and Health Care Benefits. Nine-month operating cash flow more than doubled to $15.32 billion. The company raised its 2026 guidance to at least $6.98 in GAAP diluted EPS and at least $15.5 billion in operating cash flow.
